Patents
Sitemap › C07 - Organic chemistry › C07H - Sugars; Derivatives thereof; Nucleosides; Nucleotides; Nucleic acids › C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892)
04/2005
04/20/2005CN1607253A Fermentative carotenoid production
04/20/2005CN1197967C Gene sequence of rockfish pituitary rich in reproductive control factor and its use
04/19/2005US6881836 Blocking; high density arrays; activation
04/19/2005US6881834 Myeloid cell promoter and constructs containing same
04/19/2005US6881832 Comprises nucleotide sequences coding signal sequences for transport of heterologous proteins into preferential cellular compartments
04/19/2005US6881831 Treating against hepatitis infections, particularly hepatitis B viral infections. Compounds of the invention are nucleic acid-based and preferably comprise 2, 3, 4, 5 or 6 nucleoside units.
04/19/2005US6881827 Molecular cloning of a 7TM receptor (AXOR34) and screening methods thereof
04/19/2005US6881589 Electrochemiluminescent formulation for electrochemiluminescent assay for an analyte containing a organometallic label, a first and a second binders for such analytes, collectable magnetic particles and an electrolyte
04/19/2005US6881563 Human proteases and polynucleotides encoding the same
04/19/2005US6881549 Polysaccharide having an aminated keto-carboxy group e.g. derived from KDO (2-keto-3-deoxy-D-manno-octonic acid))
04/19/2005US6881536 Particle based electrochemiluminescent assays
04/19/2005US6881404 Enzymatic protein for treating inflammation, thrombosis andrestenosis
04/19/2005US6881401 Methods of treatment of immune system related disorders using Neutrokine-alpha
04/19/2005US6881317 Fractionation of macro-molecules using asymmetric pulsed field electrophoresis
04/19/2005CA2263713C Lyophilization of cultured human cells to preserve rna and dna
04/14/2005WO2005033694A2 Novel antisense oligomers and use thereof
04/14/2005WO2005033662A2 Foreign pas ligands regulate pas domain function
04/14/2005WO2005033661A2 Dmbt1 as a clinical marker and uses thereof
04/14/2005WO2005033652A2 Methods for comparing relative flux rates of two or more biological molecules in vivo through a single protocol
04/14/2005WO2005033340A2 Methods and kits for hybridizing multiple probe panels to nucleic acid samples
04/14/2005WO2005033293A2 Hypoxia - responsive human cngh-0002 genes and polypeptides
04/14/2005WO2005033287A2 Methods for identifying a biosynthetic pathway gene product
04/14/2005WO2005033284A2 Compositions and methods for gene expression
04/14/2005WO2005033270A2 Vectors and transfected cells
04/14/2005WO2005033265A2 Optimized multi-epitope constructs and uses thereof
04/14/2005WO2005033158A2 Attachment of molecules to surfaces
04/14/2005WO2005033144A2 Tim-3 polypeptides
04/14/2005WO2005033141A1 Regulation of matrix metalloproteinases by psp94 family members
04/14/2005WO2005033136A1 Unique integrin binding site in connective tissue growth factor (ctgf)
04/14/2005WO2005033134A2 Secreted protein therapeutics and uses thereof
04/14/2005WO2005033133A2 Polynucleotides encoding erbb-2 polypeptides and kits and methods using same
04/14/2005WO2005033132A2 Igf binding proteins
04/14/2005WO2005033125A2 Mammalian t1r3 sweet taste receptors
04/14/2005WO2005032496A2 Hydrolases, nucleic acids encoding them and mehods for making and using them
04/14/2005WO2005032476A2 Methods and compositions for cpg15-2
04/14/2005WO2005032461A2 Novel peptide with osteogenic activity
04/14/2005WO2005032399A2 Il4 receptor antagonists for horse, dog and cat
04/14/2005WO2005032328A2 Compositions, kits, and methods for identification, assessment, prevention, and therapy of rheumatoid arthritis
04/14/2005WO2005003315A3 Compositions and methods for peptide-assisted transfection
04/14/2005WO2004112706A3 Vaccines, immunotherapeutics and methods for using the same
04/14/2005WO2004111190A3 IN VIVO HIGH THROUGHPUT SELECTION OF EFFECTIVE RNAi PROBES
04/14/2005WO2004108890A3 Dilute methanol -or ethanol- induced production of polypeptides in microorganisms
04/14/2005WO2004101739A3 Methods for chemically synthesizing immunoglobulin chimeric proteins
04/14/2005WO2004083816A3 Loss of heterozygosity of the dna markers in the 12q22-23 region
04/14/2005WO2004083378A3 Mammalian cell lines specifically deficient in o-linked glycosylation
04/14/2005WO2004047767A3 Methods for identifying risk of breast cancer and treatments thereof
04/14/2005WO2004046168A3 Recombinant hiv-1 subclass d envelope glycoproteins
04/14/2005WO2004044140A3 2’-substituted oligomeric compounds and compositions for use in gene modulations
04/14/2005WO2004039307A3 Methods and compositions for diagnosing and treating companion animal cancer
04/14/2005WO2004035676A3 Antisense modulation of notch (drosophila) homolog 4 expression
04/14/2005WO2004031105A3 Use of a33 antigens and jam-it
04/14/2005WO2004026266A3 SYNTHESIS AND APPLICATIONS OF TRINUCLEOTIDE pCpCpA-3′-NH-AMINOACYL DERIVATIVES
04/14/2005WO2004013609A3 Use of biomarkers for detecting ovarian cancer
04/14/2005WO2004011485A3 Stabilized bioactive peptides and methods of identification, synthesis, and use
04/14/2005WO2003040322A3 Promoters for regulation of gene expression in plant roots
04/14/2005WO2003027228A3 Receptors and membrane-associated proteins
04/14/2005WO2002079417A3 Methods of delivery of exogenous proteins to the cytosol and uses thereof
04/14/2005US20050081266 Modulation of storage organs
04/14/2005US20050081263 Cholorophyllases
04/14/2005US20050080248 Multimeric oxidoreductases
04/14/2005US20050080247 Leinamycin biosynthesis gene cluster and its components and their uses
04/14/2005US20050080246 Compositions comprising alternating 2'-modified nucleosides for use in gene modulation
04/14/2005US20050080233 Expression vector comprising nucleotide sequences coding bacterial outer membrane protein for use in diagnosis, prevention and treatment of microorganismal infection
04/14/2005US20050080031 Nucleic acid treatment of diseases or conditions related to levels of Ras, HER2 and HIV
04/14/2005US20050079610 Using short interfering RNA's specific to oncogene (fos) as tool in prevention and treatment of infection, allergies, cell proliferatiove, inflammatory and autoimmune diseases
04/14/2005US20050079605 Glycosylation engineering of antibodies for improving antibody-dependent cellular cytotoxicity
04/14/2005US20050079585 Complement depletion using recombinant human C3-derivatives
04/14/2005US20050079582 chimeric polypeptide molecules inhibits neoplastic cell growth or inhibits endothelial cell growth
04/14/2005US20050079579 Uses of spatial configuration to modulate protein function
04/14/2005US20050079578 Generating transgenic cell which express keratinocyte growth factor-2 (KGF-2) for use ase tool in treatment of ulcers and inflammatory bowel disease
04/14/2005US20050079576 Binding polypeptide, for use in the detection and treatment of prostate cancer
04/14/2005US20050079567 Modified luciferase
04/14/2005US20050079529 Using laser excitation and fluorescence to identify regions of hybridization along microarray comprised of immobilized polynucleotides; gene expression analysis; genomics
04/14/2005US20050079527 Bisulfite method
04/14/2005US20050079525 Long wavelength engineered fluorescent proteins
04/14/2005US20050079515 Compositions, splice variants and methods relating to breast specific nucleic acids and proteins
04/14/2005US20050079510 Bead emulsion nucleic acid amplification
04/14/2005US20050079493 DNA fingerprinting using allelic specific oligonucleotide reversed dot blot (ASO-RDB) flow through hybridization process and device
04/14/2005CA2840691A1 Methods for comparing relative flux rates of two or more biological molecules in vivo through a single protocol
04/14/2005CA2545639A1 Regulation of matrix metalloproteinases by psp94 family members
04/14/2005CA2542021A1 Dmbt1 as a clinical marker and uses thereof
04/14/2005CA2541823A1 Hypoxia responsive human cngh 0002 genes and polypeptides
04/14/2005CA2541015A1 Igf binding proteins
04/14/2005CA2541006A1 Tim-3 polypeptides
04/14/2005CA2540837A1 Mammalian t1r3 sweet taste receptors
04/14/2005CA2540665A1 Human epo mimetic hinge core mimetibodies, compositions, methods and uses
04/14/2005CA2536303A1 Attachment of molecules to surfaces
04/14/2005CA2530789A1 Methods for comparing relative flux rates of two or more biological molecules in vivo through a single protocol
04/14/2005CA2515583A1 Hydrolases, nucleic acids encoding them and methods for making and using them
04/13/2005EP1522583A2 RNA interference mediated inhibition of placental growth factor gene expression using short interfering nucleic acid (sina)
04/13/2005EP1521849A2 Hepatitis a virus nucleotide sequences, recombinant proteins and uses thereof
04/13/2005EP1521772A1 Mutant proteins and use thereof for the manufacture of medicaments and the treatment of humans or animals suffering from conformational diseases
04/13/2005EP1521768A2 RNA INTERFERENCE MEDIATED INHIBITION OF VASCULAR ENDOTHELIAL GROWTH FACTOR AND VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
04/13/2005EP1521767A2 Methods and constructs for high yield expression of clostripain
04/13/2005EP1425414A4 Genetic markers for improved disease resistance in animals (nramp1)
04/13/2005EP1015469B1 Bi- and tri-cyclic nucleoside, nucleotide and oligonucleoide analogues
04/13/2005EP0915897B1 Process for combining parallel oligonucleotide synthesis and preparation of oligomer chips
04/13/2005EP0854935B1 Method for contiguous genome sequencing
04/13/2005EP0728210B1 Thrombin mutants
04/13/2005EP0689609B2 Process for typing hla-b using specific primers and probes sets
1 ... 575 576 577 578 579 580 581 582 583 584 585 586 587 588 589 590 591 592 593 594 595 ... 899